penn medicine
penn surgery
penn surgery home penn surgery clinical penn surgery education penn surgery research penn surgery administration

Pavan Atluri, M.D.
Cardiovascular Surgery

  
  • Profile Home
  • Appointments
  • Education
  • Societies
  • Research
  • Publications
  • Awards

Administrative Office:
Hospital of the University of Pennsylvania
3400 Spruce Street
6 Silverstein Pavilion
Philadelphia, Pennsylvania 19104
Administrative Assistant: Shanella Burton
Administrative Telephone: 215-662-2956
Administrative Fax: 215-349-5798

Clinical Office:
Perelman Center for Advanced Medicine
Penn Heart and Vascular Center
East Pavilion, 2nd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
Clinical Telephone: 215-662-2956
Clinical Fax: 215-349-5798

Contact Information (internal use only)

pavan.atluri@uphs.upenn.edu

 

Dr. Pavan Atluri completed his general surgery and cardiothoracic surgery training at the University of Pennsylvania. He remains on faculty in the division of cardiovascular surgery. Dr. Atluri’s clinical interests are focused on minimally invasive cardiovascular and valvular surgery, mechanical circulatory support, cardiac transplantation and conventional and molecular myocardial revascularization. His research interests are in the areas of minimally invasive cardiac surgery, myocardial neovascularization, myocardial regeneration, and management of heart failure. Dr. Atluri has a translational research lab focused on tissue engineering, progenitor cell mediated myocardial vasculogenesis and myocardial regeneration.
 
Faculty Appointments
2011 - present Assistant Professor of Surgery
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
2011 - present Assistant Professor of Surgery
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
 
2011 - present Assistant Professor of Surgery
Pennsylvania Hospital
Philadelphia, Pennsylvania
 
Hospital and Administrative Appointments
2015 - present Main Council Member, Council on Cardiovascular Surgery and Anesthesia
American Heart Association
 
2014 - present  Director, Heart Transplant and Mechanical Circulatory Support
University of Pennsylvania Health System
Philadelphia, Pennsylvania
 
2014 - present  Director, Minimally Invasive and Robotic Cardiac Surgery Program
University of Pennsylvania Health System
Philadelphia, Pennsylvania
 
2014 - present   Co-Director, Heart Failure Center of Excellence, Heart and Vascular Center
University of Pennsylvania Health System
Philadelphia, Pennsylvania
 
2012 - present  Grant Reviewer, American Heart Association, Surgery Subsection
 
2011 - present Attending Surgeon
Division of Cardiovascular Surgery
Hospital of the University of Pennsylvania
University of Pennsylvania Health System
Philadelphia, Pennsylvania
 
2011 - present  Attending Surgeon
Division of Cardiovascular Surgery
Penn Presbyterian Medical Center
University of Pennsylvania Health System
Philadelphia, Pennsylvania
 
2011 - present  Attending Surgeon
Division of Cardiovascular Surgery
Pennsylvania Hospital
University of Pennsylvania Health System
Philadelphia, Pennsylvania
 
2011 - 2015 Council on Cardiovascular Surgery and Anesthesia Membership and Communications Council, American Heart Association
 
2009 - 2011 Young Leadership Committee, Council of Cardiovascular Surgery and Anesthesia
American Heart Association
 
2009 - 2010 Administrative Chief Resident, Cardiothoracic Surgery
University of Pennsylvania
Philadelphia, Pennsylvania
 
2005 - 2006 President, All House-Staff Committee
University of Pennsylvania Health System
Philadelphia, Pennsylvania
 
2005 - 2006 Chair, Residents’ Executive Council
Department of Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
2005 - 2006 Housestaff Representative, Patient Flow Project Steering Committee
University of Pennsylvania Health System
Philadelphia, Pennsylvania
 
2005 - 2006 Housestaff Representative, Graduate Medical Education Committee
University of Pennsylvania Health System
Philadelphia, Pennsylvania
 
2005 - 2006  Housestaff Representative, Medical Board
University of Pennsylvania Health System
Philadelphia, Pennsylvania
 
2004 - 2005 Chair Elect, Residents’ Executive Council
Department of Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
Education/Training
1994 - 1998 BS - Biology-Sociology, Summa cum Laude
Union College
Schenectady, New York
 
1997 - 2001 MDDR - Doctor of Medicine with Distinction in Research
Albany Medical College
Albany, New York
 
Postgraduate Training and Fellowship Appointments
2001 - 2002 Internship in General Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
2002 - 2008 Residency in General Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
2004 - 2006 Post-Doctoral Research Fellow
Harrison Department of Surgical Research
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
2007 - 2008 Chief Resident in General Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
2008 - 2010 Resident in Cardiothoracic Surgery (Cardiac Track)
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
2010 -2011 Fellow, Cardiovascular Surgery - Heart-Failure, Transplantation,
and Mechanical Circulatory Support; Minimally Invasive Cardiac Surgery
Division of Cardiovascular Surgery
Department of Surgery, University of Pennsylvania
Philadelphia, Pennsylvania
 
Memberships/Societies
 
National/International Societies
  • Alpha Omega Alpha (AOA)
  • Fellow (FACS), American College of Surgeons (ACS)
  • Fellow (FAHA), American Heart Association (AHA), Council on Cardiovascular Surgery and Anesthesia
  • Association for Academic Surgery (AAS)
  • American Association for Thoracic Surgery (AATS) – elected member
  • International Society for Heart Research (ISHR), American Section
  • International Society for Heart and Lung Transplantation (ISHLT)
  • International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS)
  • National Eagle Scout Association
  • Phi Beta Kappa
  • The Society of Thoracic Surgeons (STS)
 
Research
1/11 - present   Principle Investigator, Division of Cardiovascular Surgery, Harrison Department of Surgical Research, University of Pennsylvania School of Medicine, Philadelphia, PA
Basic Science: Novel Angiogenic Tissue Engineering to Treat Ischemic Heart Failure
Clinical Science: Optimization of Mechanical Circulatory Support; Intra- and Peri-Operative Management of Orthotopic Heart Transplantation; Optimization of Robotic and Minimally Invasive Mitral Valve Surgery Outcomes     
 
7/04 - 7/06 Postdoctoral Research Fellowship: Endothelial progenitor cell mediated neovasculogenesis to treat ischemic cardiomyopathy
Y. Joseph Woo, M.D., Mentor
Division of Cardiothoracic Surgery
Department of Surgery
University of Pennsylvania School of Medicine
Philadelphia, PA
 
4/03 - 12/10  Research Resident
Basic Science: Angiogenesis as a novel means to treat ischemic cardiomyopathy
Clinical: Examine modalities to optimize off-pump coronary artery bypass grafting, orthotopic heart transplantation, and mechanical cardiac assistance
Y. Joseph Woo, M.D., Mentor
Division of Cardiothoracic Surgery
Department of Surgery
University of Pennsylvania School of Medicine
Philadelphia, PA
 
9/97 - 5/01 M.D. with Distinction in Research (M.D.D.R)
Thesis: Expression of functional nicotinic acetylcholine receptors on early embryonic cerebral cortical cells
Allan S. Schneider, PhD., Mentor
Department of Neuropharmacology and Neuroscience
Albany Medical College
Albany, New York
 
6/99 - 9/99 Research Fellowship – Characterization of cerebral nicotinic receptors and their role in the developmental sequence of the fetal mouse cerebral cortex
Allan S. Schneider, PhD., Mentor
Department of Neuropharmacology and Neuroscience
Albany Medical College
Albany, New York
 
6/96 - 9/96  Research Intern – Utilized molecular genetic principles to increase cellular production of pharmaceuticals
Division of Biotechnology
Bristol-Myers Squibb Corporation
Syracuse, New York
 
11/95 - 6/96 Research Assistant – Polymer density analysis as a means of fractionating plastics for recycling
Department of Chemistry
Union College
 
Publications
Research Publications, Peer Reviewed
  1. Atluri P, Fleck MW, Shen Q, Mah SJ, Stadfelt D, Barnes W, Goderie S, Temple S, and Schneider AS. Functional nicotinic acetylcholine receptor expression in stem and progenitor cells of the early embryonic mouse cerebral cortex. Developmental Biology 2001; 240: 143-156.
  2. Schneider AS, Atluri P, Shen Q, Barnes W, Mah SJ, Stadfelt D, Goderie SK, Temple S, and  Fleck MW. Functional nicotinic acetylcholine receptor expression on stem and progenitor cells of the early embryonic nervous system. Ann. N.Y. Acad. Sci. 2002;971: 135-138.
  3. Woo YJ, Atluri P, Grand TJ, Hsu V, Gardner TJ. Should protamine dosing formulas be recalculated for off-pump coronary artery bypass grafting?  Heart Surg Forum. 2003; 7: 42-44.
  4. Atluri P, Raper S. Factor V leiden and post-operative deep vein thrombosis in patients undergoing open roux-en-y gastric bypass surgery. Obes Surg. 2005; 15:561-564.
  5. Woo YJ, Atluri P, Grand TJ, Hsu V, Cheung A. Active thermoregulation improves off-pump coronary artery bypass grafting outcomes.  Asian Cardiovasc Thor Ann 2005; 13:157-160.
  6. Woo YJ, Grand T, Berry MF, Atluri P, Moise A, Hsu V, Cohen J, Fisher O, Burdick J, Taylor M, Zentko S, Liao G, Smith M, Kolakowski S, Jayasankar V, Gardner TJ, Sweeney HL. Stromal-cell derived factor and granulocyte monocyte-colony stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. J Thor Cardiovasc Surg. 2005; 130: 321-329.
  7. Woo YJ, Grand TJ, Zentko S, Cohen JE, Hsu V, Atluri P, Berry MF, Taylor MD, Moise MA, Burdick J, Fisher O, Kolakowski S.  Creatine phosphate administration preserves myocardial function in a model of off-pump coronary revascularization.  J Cardiovasc Surg. 2005; 46:297-303.
  8. Atluri P, Liao GP, Panlilio CM, Hsu VM, Leskowitz MJ, Morine KJ, Cohen JE, Berry MF, Suarez EE, Murphy DA, Lee WMF, Gardner TJ, Sweeney HL, Woo YJ. Neovasculogenic therapy with granulocyte-monocyte colony stimulating factor and stromal cell derived factor-1α augments perfusion, reverses ischemia and preserves cardiomyocyte viability in ischemic cardiomyopathy. Ann Thor Surg. 2006; 81: 1728-1736.
  9. Cohen JE, Atluri P, Taylor MD, Grand TJ, Liao GP, Panlilio CM, Suarez EE, Zentko SE, Hsu VM, Berry MF, Smith MJ, Gardner TJ, Sweeney HL, Woo YJ. Fructose 1,6-diphosphate Administration Attenuates Post-Ischemic Ventricular Dysfunction. J Heart Lung Circ. 2006; 2: 119-123.
  10. Kolakowski S, Berry MF, Grand TJ, Fisher O, Moise MA, Cohen JE, Hsu V, Atluri P, Woo YJ. Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy. J Card Surg. 2006; 21: 559-564.
  11. Woo YJ, Panlilio CM, Cheng RK, Liao GP, Atluri P, Hsu VM, Cohen JE, Chaudhry HW.  Therapeutic Delivery of Cyclin A2 Induces Myocardial Regeneration and Enhances Cardiac Function in Ischemic Heart Failure. Circulation. 2006; 114(1 Suppl): I206-13.
  12. Atluri P, Neligan PJ, Acker MA, Bensall DL, Horak J. Prone Positioning to Treat Acute Severe Pulmonary Edema in the Post-Cardiac Surgical Patient. Heart Surg Forum. 2006; 9: 762-4.
  13. Hsu VM, Atluri P, Keane M, Woo YJ. Minimally invasive aortic valve papillary fibroelastoma resection. Interactive Cardio Thor Surg. 2006; 5: 779-781.
  14. Woo YJ, Rodriguez E, Atluri P, Chitwood WR. Minimally-invasive, robotic, and off-pump mitral valve surgery. Seminars Thor Cardiovasc Surg 2006; 18: 139-47.
  15. Atluri P, Morine KJ, Liao G, Panlilio CM, Berry MF, Hsu VM, Cohen J, Smith M, Suarez E, Sweeney HL, Woo YJ. Ischemic heart failure enhances endogenous myocardial apelin ligand and apj receptor expression. Cell & Mol Bio Lett 2007; 12:127-138.
  16. Atluri P, Woo YJ. High risk ascending aortic aneurysm repair resulting from giant cell aortitis. Asian Cardiovasc Thor Ann 2007; 15: 252-254. 
  17. Woo YJ, Panlilio CM, Cheng RK, Liao GP, Suarez EE, Atluri P, Chaudhry HW.  Myocardial regeneration therapy for ischemic cardiomyopathy with cyclin a2. J Thor Cardiovasc Surg 2007; 133; 4:927-933.
  18. Atluri P, Panlilio CM, Liao GP, Suarez EE, McCormick RC, Hiesinger W, Cohen JE, Smith MJ, Patel AB, Feng W, Woo YJ. Transmyocardial revascularization enhances myocardial vasculogenesis and hemodynamic function. J Thor Cardiovasc Surg 2008; 135; 2:283-291.
  19. Atluri P, Hiesinger W, Gorman RC, Pochettino A, Jessup M, Acker MA, Morris RJ, Woo YJ. Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure. J Cardiothor Surg 2008; 3:26-30.
  20. Atluri P, Woo YJ. Pro-angiogenic cytokines as cardiovascular therapeutics: assessing the potential. BioDrugs 2008; 22: 209-222.
  21. Atluri P, Kozin ED, Hiesinger W, Woo YJ. Off-pump, minimally invasive, and robotic coronary revascularization yield improved outcomes over traditional on-pump CABG. Int J Med Robot 2009; 5: 1-12.
  22. Augostides JGT, Atluri P. Progress in mitral valve disease: understanding the revolution. J Cardiovasc Anesth 2009; 23: 916-923. 
  23. Atluri P, Panlilio CM, Liao GP, Hiesinger W, Harris DA, McCormick RC, Cohen JE, Jin T, Feng W, Levit RD, Dong N, Woo YJ. Acute myocardial rescue with endogenous endothelial progenitor cell therapy. Heart, Lung, Circulation 2010; 11; 644-654.
  24. Woo YJ, Atluri P. Angiogenesis and surgical or endovascular enhancement of non-coronary collateral circulation:  a new research field. J Thor Cardiovasc Surg. 2010; 139:1676-1677. 
  25. Atluri P. Myocardial transfection of adeno-hypoxia inducible factor-1α, a novel strategy to potentiate vasculogenesis in ischemic myocardium.  Circ J. 2010; 74:846-847.
  26. Frederick JR, Fitzpatrick JR, McCormick RC, Harris DA, Kim AY, Muenzer JR, Marotta N, Smith MJ, Cohen JE, Hiesinger W, Atluri P, Woo YJ. Stromal cell-derived factor-1α activation of tissue engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis. Circulation 2010; 122; S107-117.
  27. Hiesinger W, Frederick JR, Atluri P, McCormick RC, Marotta N, Muenzer JR, Woo YJ. Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction. J Thor Cardiovasc Surg 2010; 140; 1174-1180.
  28. Atluri P, Acker MA. Pulsatile LVADs: What is the role in the modern era? Semin Thor Cardiovasc Surg 2010; 22; 106-108. 
  29. Atluri P, Woo YJ. Minimally invasive, robotic mitral valve surgery: equivalent technical outcomes with improved morbidity. Expert Rev Medical Devices 2011; 8; 115-120.
  30. Atluri P. Careful echocardiographic analysis of right ventricular function as a long-term prognostic variable in systolic heart failure. Circ J. 2011; 75: 2054-2055.
  31. Hiesinger W, Vinogradov S, Atluri P, Fitzpatrick JR, Frederick J, Levit R, McCormick R, Muenzer J, Yang E, Marotta N, MacArthur J, Wilson D, Woo YJ. Oxygen-dependent quenching of phosphorescence used to characterize improved myocardial oxygenation resulting from targeted endothelial progenitor cell therapy. J Appl Physio.2011 May;110(5):1460-1465
  32. Atluri P, Acker MA, Jessup ML. The next decade in mechanical assist - advances that will help the patient and the doctor. Current Opin Cardiol 2011; 26:256-260.
  33. Hiesinger W, Perez-Aguilar JM, Atluri P, Marotta N, Frederick JR, Fitzpatrick JR, McCormick RC, Muenzer JR, Levit RD, Yuan LJ, MacArthur JW, Saven JG, Woo YJ. Computational protein design to re-engineer stromal cell-derived factor-1α (SDF) generates a supra-efficient angiogenic polypeptide analog. Circulation 2011; 124:S18-26.
  34. Atluri P, MacArthur JW. A novel strategy to improve end organ function with pulsatile cardiopulmonary bypass. Circ J. 2012; 76: 1087-1088.
  35. Hiesinger W, Brukman MJ, McCormick RC, Fitzpatrick JR, Frederick JR, Yang EC, Muenzer JR, Marotta NA, Berry MF, Atluri P, Woo YJ. Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor-1α angiogenic therapy for acute myocardial infarction in a murine model. J Thoracic and Cardiovasc Surg. 2012; 143:962-966.
  36. Atluri P, Acker MA. Mitral valve surgery for dilated cardiomyopathy - current status and future role. Sem Thor Cardiovasc Surg. 2012 Spring; 24:51-8. 
  37. Atluri P, Ullery BW, MacArthur JW, Goldstone AB, Fairman AS, Hiesinger W, Acker MA, Woo YJ. Rapid onset of fulminant myocarditis portends a favorable prognosis and ability to bridge mechanical support to recovery. Eur J Cardiothor Surg. 2013; 43: 379-382.
  38. MacArthur JW, Trubelja A, Shudo Y, Hsiao P, Fairman A, Yang E, Hiesinger W, Atluri P, Woo YJ.  Mathematically-engineered stromal cell-derived factor 1alpha stem cell cytokine analogue enhances mechanical properties of infarcted myocardium. J Thorac Cardiovasc Surg. 2013; 145:278-284.
  39. Atluri P, Acker MA. Diastolic ventricular support with cardiac support devices: an alternative approach to prevent adverse ventricular remodeling. Heart Failure Rev. 2013; 18:55-63.
  40. Goldstone  AB, Atluri P, Szeto WY, Trubelja A, Howard JL, MacArthur JW, Gorman RC,  Gorman JH, Pochettino A, Bavaria JE, Acker MA, Hargrove WC, Woo YJ. Propensity score adjusted comparison of minimally invasive versus sternotomy approaches to isolated mitral valve repair. J Thor Cardiovasc Surg. 2013; 145: 748-758. 
  41. Vernick W, Atluri P. Robotic and minimally invasive cardiac surgery. Anesthes Clin 2013; 31: 299-320.
  42. Atluri P, Goldstone AB, Fairman AS, MacArthur JW, Shudo Y, Cohen JE, Acker AL, Hiesinger W, Howard JL, Acker MA, Woo YJ. Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era. Ann Thor Surg. 2013; 96: 857-864. 
  43. Atluri P, Goldstone AB, Kobrin DM, Cohen JE, MacArthur JW, Howard JL, Jessup ML, Rame JE, Acker MA, Woo YJ. Ventricular assist device implant in the elderly is associated with increased, but respectable risk. Ann Thor Surg. 2013; 96:141-147.
  44. Gutsche J, Atluri P, Augostides JG. Treatment of ventricular assist-device-associated gastrointestinal bleeding with hormonal therapy. J Cardiothor Vasc Anesth. 2013; 27; 939-943. 
  45. Atluri P, Trubelja A, Fairman AS, Hsiao P, MacArthur JW, Cohen JE, Shudo Y, Frederick JR, Woo YJ. Normalization of post-infarct biomechanics utilizing a novel tissue engineered angiogenic construct. Circulation. 2013; 128: S95-104
  46. Shudo Y, Cohen JE, MacArthur JW, Atluri P, Hsaio P, Yang E, Fairman AS, Trubelja A, Patel J, Miyagawa S, Sawa Y, Woo YJ. Spacially-oriented, temporally-sequential smc-epc bi-level cell-sheet neovascularizes ischemic myocardium. Circulation. 2013; 128: S59-68. 
  47. Atluri P, Dymond DJ, Woo YJ. Continuous flow left ventricular assist device implantation in the presence of a hostile ventricle. J Thor Cardiovasc Surg. 2013; 146: 981-982.
  48. MacArthur JW. Purcell B, Shudo Y, Cohen JE, Fairman AS, Trubelja A, Patel J, Hsaio P, Yang E, Lloyd K, Hiesinger W, Atluri P, Woo YJ. Sustained release of engineered stromal cell-derived factor 1-alpha from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function following myocardial infarction. Circulation. 2013; 128:S79-86. 
  49. MacArthur JW, Cohen JE, Goldstone AB, Fairman AS, Edwards BB, Hornick MA, Atluri P, Woo YJ. Nonresectional single-suture leaflet remodeling for degenerative mitral regurgitation facilitates minimally invasive mitral valve repair. Ann Thor Surg. 2013; 96:1603-1606.
  50. Atluri P, Woo YJ, Goldstone AB, Fox J, Acker MA, Szeto WY, Hargrove WC. Minimally invasive mitral valve surgery can be performed with optimal outcomes in the presence of left ventricular dysfunction. Ann Thor Surg. 2013; 96:1596-1601. 
  51. Atluri P, Fairman AS, MacArthur JW, Howard JL, Yang E, Shudo Y, Hiesinger W, Woo YJ. Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility and tricuspid valve competence. J Card Surg. 2013; 28:770-775.
  52. Gutsche JT, Kornfield ZN, Speck RM, Patel PA, Atluri P, Augostides YG. Impact of guideline implementation on transfusion practices in a surgical intensive care unit. J Cardiothor Vasc Anest. 2013; 28:770-775. 
  53. Hiesinger W, Cohen JE, Atluri P. Therapeutic potential of Rb phosphorylation in atherosclerosis. Cell Cycle. 2013; 13:352.
  54. Rame E, Atluri P, Acker MA. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014; 370: 1466-1467. 
  55. Atluri P, Miller JS, Emery RJ, Hung G, Trubelja A, Cohen JE, Lloyd K, Han J, Gaffey AC, Patel JB, MacArthur JW, Chen CS, Woo YJ. Tissue engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function. J Thor Cardiovasc Surg 2014; 148: 1090-1097.
  56. Trubelja A, MacArthur JW Jr, Sarver JJ, Cohen JE, Hung G, Shudo Y, Fairman AS, Patel JB, Edwards BB, Damrauer SM, Hiesinger W, Atluri P, Woo YJ. Bioengineered sdf-1a analogue delivered as an angiogenic therapy significantly restores viscoelastic material properties of infarcted cardiac muscle. J Biomech Eng 2014: 138.
  57. Cohen JE, Purcell BP, MacArthur JW, Mu A, Shudo Y, Patel JB, Brusalis CM, Trubelja A, Fairman AS, Edwards BB, Davis MS, Hung G, Hiesinger W, Atluri P, Margulies KB, Burdick JA, Woo YJ. A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy. Circ Heart Fail 2014; 4:619-626.
  58. MacArthur JW, Cohen JE, McGarvey J, Shudo Y, Patel JB, Trubelja A, Fairman A, Edwards BB, Hung G, Goldstone AB, Hiesinger W, Atluri P, Wilensky RL, Pilla J, Gorman JH, Gorman RC, Woo YJ. Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1-alpha analogue in a translational ovine myocardial infarction model. Circ Res 2014; 114:650-659.
  59. Atluri P, Gaffey A, Howard J, Phillips E, Goldstone AB, Hornsby N, MacArthur JW, Cohen JE, Gutsche J, Woo YJ. Combined heart and liver transplantation can be safely performed with excellent short- and long-term results. Ann Thor Surg 2014; 98:858-862.
  60. Atluri P, Goldstone AB, Fox Jeanne, Szeto WY, Hargrove WC. Port access cardiac surgery can be safely performed utilizing either endoaortic balloon or chitwood clamp. Ann Thor Surg 2014; 98:1579-1583.
  61. Vernick W, Szeto WY, LI RJ, Atluri P, Augostides JG, Kukafka JD, Patel PA, Gutsche JT. The utility of atrioventricular pacing via a pulmonary artery catheter during transcatheter aortic valve replacement. J Cardiothor Vasc Anesth – In Press. 
  62. Goldstone AB, Howard JL, Cohen JE, MacArthur JW, Atluri P, Kirkpatrick JN, Woo YJ. Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease:implications for future guidelines. J Thor Cardiovasc Surg 2014; 148:1090-1097. 
  63. Bartoli CR, Restle D, Zhang D, Acker MA, Atluri P. von Willebrand Factor Degradation with an LVAD Occurs via Two Distinct Mechanisms:Mechanical Demolition and Enzymatic Cleavage. J Thor Cardiovasc Surg 2015; 149:281-289.
  64. DeLong MR, Hughes DB, Gaca JG, Fischer J, Bond JE, Hargrove WC, Atluri P, Levin LS, Erdmann D. Sternal talon offers a solution for secondary sternum osteosynthesis in patients with nonunion. Ann Thor Surg 2014; 98:1579-1583.
  65. Kornfield NZ, Horak J, Gibbs RM, Weiss SJ, Atluri P, Augostides JG, Gutsche JT, Sidebotham D. Extracorporeal membrane oxygenation as a bridge to clinical recovery in life-threatening autoimmune acute respiratory distress syndrome. J Cardiothor Vasc Anesth 2015; 29:221-228.
  66. Gaffey AC, Phillips EC, Howard J, Hung G, Han J, Emery RJ, Goldberg L, Acker MA, Woo YJ, Atluri P. Prior sternotomy and ventricular assist device implant do not adversely impact survival or allograft function following heart transplant. Ann Thor Surg 2015; 100:542-549.
  67. Goldstone AB, Cohen JE, Howard JL, Edwards BB, Acker AL, Hiesinger W, MacArthur JW, Atluri P, Woo YJ. A “repair-first” strategy for degenerative mitral valve disease safely minimizes unnecessary replacement. Ann Thor Surg 2015; 99:1983-1990.
  68. Atluri P, Woo YJ. Combined Heart-Liver Transplantation Experience and Improved Organ Utilization – reply. Ann Thor Surg 2015; 99:1489.
  69. Restle DJ, Zhang DM, Hung G, Howard JL, Kallel F, Acker MA, Atluri P, Bartoli CR. Preclinical models for translational investigations of lvad-associated von willebrand factor degradation Artif Organs 2015; 39:569-575.
  70. Shudo Y, Cohen JE, MacArthur JW, Goldstone AB, Hiraoka A, Howard J,  Fairman, AS, Patel J, Edwards BE, Atluri P, Woo YJ. Non-resectional leaflet remodeling mitral valve repair preserves leaflet mobility: a quantitative echocardiographic analysis of mitral valve configuration. Int J Cardiol 2015; 186: 16-18.
  71. Birati EY, Quiaoit Y, Wald J, Kirkpatrick JN, Goldberg LR, Atluri P, Margulies KB, Rame JE. Ventricular assist device thrombosis: a wide spectrum of clinical presentation. J Heart Lung Transp 2015; 34: 613-615.
  72. Hiraoka A, Cohen JE, Shudo Y, MacArthur JW, Howard JL, Fairman AS, Atluri P, Kirkpatrick JN, Woo YJ. Evaluation of late aortic insufficiency with continuous flow left ventricular assist device. Eur J Cardiothorac Surg 2015; 48: 400-406.
  73. Kornfield ZN, Korak J, Gibbs RM, Weiss SJ, Atluri P, Augostides JG, Gutsche JT, Sidebotham D. Extracorporeal membrane oxygenation as a bridge to clinical recovery in life-threatening autoimmune acute respiratory distress syndrome. J Cardiothorac Vasc Anesth 2015; 29: 221-228.
  74. Gaffey AC, Atluri P. Post-LVAD right ventricular failure: can it be predicated pre-operatively and should it be a contraindication to implant? J Thorac Cardiovasc Surg 2015; 6:1659-60.
  75. McCarthy FH, McDermott KM, Kini V, Gutsche JT, Wald JW, Xie D, Szeto WY, Bermudez CA, Atluri P, Acker MA, Desai ND. Trends in U.S. extracorporeal membrane oxygenation use and outcomes: 2002-2012. Semin Thorac Cardiovasc Surg 2015; 27:81-88.
  76. Bartoli CR, Kang J, Restle DJ, Zhang DM, Shabahang C, Acker MA, Atluri P. Inhibition of ADAMTS-13 by doxycycline reduces vonWillebrand factor degredation during supraphysiologic shear stress: therapeutic implications of left ventricular assist device associated bleeding. JACC Heart Fail 2015; 11:860-869.
  77. Gaffey AC, Chen MH, Venkataraman C, Trubelja AS, Rodell CB, Dinh PV, Hung G, MacArthur JW, Soopan RV, Burdick JA, Atluri P. Injectable shear-thinning hydrogels to deliver endothelial progenitor cells to enhance cell engraftment and improve ischemic myocardium. J Thorac Cardiovasc Surg 2015; 150:1268-1277.
  78. Bartoli CR, Atluri P. Do patients with continuous flow devices benefit from induced pulsatility or are we just spinning our wheels? J Thorac Cardiovasc Surg 2015; 150:945-946.
  79. Sultan I, Atluri P. Total endovascular arch replacement: Are we there yet? Are we there yet? J Thor Cardiovasc Surg 2015; epub ahead of press.
  80. Shudo Y, Choen JE, MacArthur JA, Trubelja A, Patel J, Edwards BB, Hung G, Fairman AS, Brusalis C, Hiesinger W, Atluri P, Hiroaka A, Miyagawa S, Sawa Y, Woo YJ, Goldstone A, Otsuru S. Tissue Eng Part A 2015; 21:2515-2525.
  81. Sooppan RV, Paulsen SJ, Han J, Ta HA, Dinh P, Gaffey AC, Venkataraman C, Trubelja AS, Hung G, Miller JS, Atluri P. In vivo implant and microvascular perfusion of a 3D printed internally vascularized  construct.  Tissue Eng Part C 2016;22:1-7.
  82. Atluri P, Stetson R, Gaffey AC, Szeto WY, Acker MA, Hargrove WC. Minimally invasive mitral valve surgery is associated with equivalent cost and shorter hospital length of stay when compared to traditional sternotomy. J Thorac Cardiovasc Surg 2016;151:385-388.
  83. Kilic A, Acker MA, Atluri P. Dealing With Surgical Left Ventricular Assist Device Complications. J Thor Dis 2015; 7:2158-2164.
  84. McCarthy FH, McDermott KM, Kini V, Gutsche JT, Wald JW, Xie D, Szeto WY, Bermudex CA, Atluri P, Acker MA, Desai ND. Trends in U.S. extracorporeal membrane oxygenation use and outcomes: 2002-2012. Sem Thorac Cardiovasc Surg 2015;27:81-88.
  85. Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, Hung YP, Voisine P, Dagenais F, Gillinov AM, Thourani V, Argenziano M, Gammie JS, Mack M, Demers P, Atluri P, Rose EA, O’Sullivan K, Williams DL, Bagiella E, Michler RE, Weisel RD, Miller MA, Geller NL, Taddei-Peters WC, Smith PK, Moquete E, Overbey JR, Kron IL, O’Gara PT, Acker MA. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med 2016;374:344-353.
  86. Hiesinger W, Atluri P. Building a better bridge: Remodeling, recovery, and a better understanding of the biologic foundation of mechanical circulatory support. J Thorac Cardiovasc Surg 2015; 150:1342-1343.
  87. Gaffey AC, Atluri P. Post-left ventricular assist device support right ventricular failure: can it be predicted preoperatively and should it be a contraindication to implantation? J Thorac Cardiovasc Surg 2015; 150:1659-1660.
  88. McCarthy FH, Kobrin D, Rame JE, Groeneveld PW, McDermott KM, Atluri P, Acker MA, Desai ND. Increasing frequency of left ventricular assist device exchange in the United States: Is there cause for concern? Ann Thor Surg 2015; 100:1660-1664.
  89. Birati EY, Mathelier H, Molina M, Hanff TC, Mazurek JA, Atluri P, Acker MA, Rame JE, Margulies KB, Goldberg LR, Jessup M. Am J Cardiol 2016 – epub ahead of press.
  90. Han J, Gaffey AC, Soopan R, Hung G, Venkataraman C, Phillips E, Howard J, Acker MA, McLean R, Atluri P. Heartmate II left ventricular assist device geometry on chest radiograph may be a dynamic marker of remodeling . ASAIO J 2016 – epub ahead of press.
  91. Gaffey AC, Cucchiara AJ, Hung G, Goldberg LR, Blumberg EA, Acker MA, Atluri P. Transplantation of center for disease control “high risk” donor hearts does not adversely impact long term outcomes in adults. J Card Failure 2016 – epub ahead of press.
  92. Gaffey AC, Hung G, Howard J, Doll S, Thomasson AM, Chen CW, Goldberg LR, Blumberg EA, Acker MA, Stone F, Atluri P. Transplantation for center for disease control “high risk” donor hearts: Implications for infection. J Thorac Cardiovasc Surg 2016- epub ahead of press.
  93. Hiesinger W, Atluri P. Hybrid coronary revascularization: ready for prime time, but who should star? J Thorac Cardiovasc Surg 2016 – epub ahead of press.
  94. Kang J, Zhang DM, Restle DJ, Kallel F, Acker MA, Atluri P, Bartoli CR. Reduced continuous-flow left ventricular assist device speed does not decrease von willebrand factor degradation. J Thor Cardiovasc Surg 2016 – epub ahead of press.
  95. Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ, Acker MA, Hung JW, Chang HL, Perrault LP, Gillinov AM, Argenziano M, Bagiella E, Overbey JR,  Moquete EG, Gupta LN, Miller MA, Taddei-Peters WC, Jeffries N, Weisel RD, Rose EA, Gammie JS, DeRose JJ, Puskas JD, Dagenais F, Burks SG, Hamamsy IE, Milano CA, Atluri P, Voisine P, O’Gara PT,  Gelijns AC. Two year outcomes following surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 2016- in press.
  96. Williams ML, Bavaria JE, Acker MA, Desai ND, Vallabhajosyula P, Hargrove WC, Atluri P, Szeto WY. Valve selection in end stage renal disease: should it always be biological? Ann Thor Surg – in press.
  97. Soopan R, Johnson AP, Gaffey AC, Phillips EC, Howard J, Acker MA, Atluri P. Body mass index does not affect survival and is a reliable independent risk predictor of vad thrombosis. J Card Surg – In submission.
  98. Grandin EW, Zamani P, Mazurek JA, Troutman GS, Birati EY, Vorovich E, Tedford RJ, Chirinos JA, Margulies KB, Atluri P, Rame JE. Right ventricular pulsatile load and hemodynamic response to load predicts right heart failure and six-month mortality after continuous-flow left ventricular assist device implantation. J Heart Lung Transp – In submission.
  99. Gaffey AC, Chen CW, Hiesinger W, Chung J, Grandin EW, Porrett PM, Jessup ML, Acker MA, Atluri P. Bridge with a left ventricular assist device to simultaneous heart and kidney transplant: review of the united network for organ sharing database. JACC Heart Failure – In submission.
  100. Gaffey AC, Chen MH, Trubelja A, Venkataraman C, Dinh PV, Chen CW, Schultz S, Lee J, Sehgal CM, Burdick JA, Atluri P. Injectable shear-thinning hydrogels to deliver endothelial progenitor cells, reduce ventricular strain, and dynamic stiffness to stabilize cardiac function following ischemic injury. Circ Heart Failure – In Submission.
Abstracts
  1. Schneider AS, Shen Q, Barnes W, Atluri P, Mah SJ, Temple S, Fleck MW.  Acquisition of functional nicotinic acetylcholine receptors during embryonic development of the mouse cerebral cortex. Society of Neurosciences Abst. 25, #408.15, November 1999.
  2. Atluri P, Shen Q, Barnes W, Mah SJ, Stadfelt D, Fleck MW, Schneider AS. Functional nicotinic acetylcholine receptor expression during early embryonic development of the mouse cerebral cortex. Arthur M. Sackler Colloquia of the National Academy of Sciences Abst. 1, #3, May 2001.
  3. Atluri P, Grand T, Berry M, Moise MA, Hsu V, Liao G, Cohen J, Fisher O, Taylor M,  Zentko S, Jayasankar V, Kolakowski S, Woo YJ. Endothelial progenitor cell mediated neovasculogenesis for the treatment of ischemic cardiomyopathy. 42th Annual Meeting of the Pennsylvania Association for Thoracic Surgery, October 9, 2004.
  4. Atluri P, Morine KJ, Liao G, Panlilio C, Berry MF, Hsu V, Cohen J, Smith M, Suarez E, Sweeney HL, Woo YJ. Ischemic heart failure increases local concentrations of the endogenous inotrope apelin-13 and the apj receptor. 27th Annual International Society of Heart Research, American Section Meeting, May 12, 2005, JMCC 2005;38:850.
  5. Moise MA, Berry MF, Atluri P, Barton-Davis E, Fairman R, Sweeney HL, Woo, YJ. Endothelial progenitor cell recruitment as a vasculogenic therapy for rat peripheral ischemia. society for vascular surgery 2005 research initiatives conference. April 7, 2005.
  6. Atluri P, Berry MF, Morine KJ, Liao GP, Panlilio CM, Hsu V, Cohen JE, Smith MJ, Suarez EE, Zentko SE, Leskowitz MJ, Gardner TJ, Sweeney HL, Woo YJ. Endogenous and exogenous apelin mediated inotropic activity enhances cardiac function in heart failure. 43th Annual Meeting of the Pennsylvania Association for Thoracic Surgery, September 29, 2005.
  7. Atluri P, Liao G, Panlilio C, Morine KJ, Berry MF, Hsu V, Cohen J, Smith M, Suarez E, Sweeney HL, Woo YJ. Treatment with granulocyte monocyte colony stimulating factor and stromal cell derived factor 1alpha enhances myocardial perfusion and viability in ischemic cardiomyopathy. American College of Surgeons, 91st Annual Clinical Congress Meeting, October 17, 2005. J Am Coll Surgeons 2005;3(Suppl):S44.
  8. Woo YJ, Panlilio CM, Cheng RK, Liao GP, Atluri P, Cohen JE, Chaudhry HW. Therapeutic delivery of cyclin A2 induced myocardial regeneration enhances cardiac function in ischemic heart failure. American Heart Association Scientific Sessions 2005, November 13, 2005.
  9. Atluri P, Liao GP, Panlilio CM, Morine KJ, Berry MF, Cohen JE, Suarez EE, Hsu V, Smith MJ, Gardner TJ, Seeney HL, Woo YJ. Neovasculogenic therapy with granulocyte-monocyte colony stimulating factor and stromal cell derived factor-1α augments perfusion, reverses ischemia and preserves cardiomyocyte viability in ischemic cardiomyopathy. American Heart Association Scientific Sessions 2005, November 13, 2005.
  10. Woo YJ, Panlilio CM, Cheng RK, Liao GP, Atluri P, Cohen JE, Chaudhry HW. Myocardial regeneration therapy for ischemic cardiomyopathy with cyclin A2. American Association for Thoracic Surgery 86th Annual Meeting, May 2, 2006.
  11. Atluri P, Morine KJ, Liao GP, Panlilio CM, Woo YJ.  Endothelial progenitor cell targeting to ischemic myocardium attenuates hypoxia and enhances cardiomyocyte viability and function.  Heart Failure Society of America, 10th Annual Scientific Meeting. September 10, 2006.
  12. Atluri P, Panlilio CM, Liao GP, Suarez EE, Cohen JE, Hye JB, Dong N, Woo YJ. Acute myocardial rescue with endogenous endothelial progenitor cell therapy. American Heart Association Scientific Sessions 2006, Vivien Thomas Young Investigator Competition, November 12, 2006.
  13. Atluri P, Panlilio CM, Liao GP, Cheng RC, Chaudhry H, Woo YJ.  Therapeutic endogenous myocardial repair and regeneration. GTCbio Modern Drug Discovery & Development Summit, December 5, 2006.
  14. Cohen JE, Suarez EE, Liao GP, Smith MJ, Atluri P, Hye JB, Panlilio CM, Woo YJ. Cripto stimulates myocardial proliferation and enhances ventricular function in ischemic cardiomyopathy. The Society of Thoracic Surgeons, 43rd Annual Meeting, January 29, 2007.
  15. Atluri P, Suarez EE, Liao GP, Panlilio CM, Hye JB, Hiesinger W, Cohen JE, Smith MJ, Woo YJ. Transmyocardial revascularization enhances myocardial vasculogenesis and hemodynamic function, American Association for Thoracic Surgeons, 87th Annual Meeting, C. Walton Lillehei Young Investigators’ Competition, May 7, 2007.
  16. Atluri P, Hiesinger W, Gorman RC, Pochettino A, Acker MA, Morris RJ, Woo YJ. Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure. Western Thoracic Surgical Association, 33rd Annual Meeting, June 30, 2007.
  17. Hiesinger W, Vinogradov SA, Levit RD, Atluri P, Feng W, Tao J, McCormick RC, Patel AB, Smith MJ, Cohen JE, Suarez EE, Wilson DF, Woo YJ.  Targeted endothelial progenitor cell therapy increases myocardial oxygen tissue pressure characterized in vivo using oxygen-dependent quenching of phosphorescence.  Heart Failure Society of America 11th Annual Meeting, September 16, 2007.
  18. Cohen JE, Atluri P, Heisinger W, McCormick R, Laporte C, Smith MJ, Hsu VM, Patel AB, Woo YJ. Cripto stimulates myocardial proliferation and enhances ventricular function in ischemic cardiomyopathy. American Heart Association Scientific Sessions 2008, November 11, 2008.
  19. Atluri P, McCormick RC, Laporte C, Liao GP, Panlilio C, Hiesinger W, Cohen JE, Gerety PA, Frederick JR, Fitzpatrick JR, Jin T, Levit RD, Smith MJ, Woo YJ. Transmyocardial laser revascularization upregulates endogenous vasculogenic signals and limits myocardial scar. International Society for Minimally Invasive Cardiothoracic Surgery 12th Annual Scientific Meeting, June 4, 2009.
  20. Frederick JR, Fitzpatrick JR, McCormick RC, Harris DA, Kim AY, Muenzer JR, Smith MJ, Cohen JE, Liu JP, Atluri P, Woo YJ. Tissue engineered endothelial progenitor cell construct promotes neovasculogenesis, enhances perfusion, and improves ventricular function after myocardial infarction. American College of Surgeons, 95st Annual Clinical Congress Meeting, October 13, 2009.
  21. Frederick JR, Fitzpatrick JR, McCormick RC, Harris DA, Kim AY, Muenzer JR, Murthy A, Hsiao PF, Prystowsky AD, Smith MJ, Cohen JE, Atluri P, Woo YJ. Stromal cell-derived factor-1α activation of tissue engineered endothelial progenitor stem cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis. American Heart Association Scientific Sesions 2009. November 15, 2009.
  22. Atluri P, Howard JL, Kozin ED, Ullery BW, Hiesinger W, Fitzpatrick JR, Jessup M, Acker MA, Morris RJ, Woo YJ. Ventricular assist devices rescue patients in cardiogenic shock without adversely impacting the complexity of subsequent heart transplantation. International Society For Heart and Lung Transplantation 30th Annual Meeting and Scientific Sessions. April 21, 2010.
  23. Hiesinger W, Frederick JR, Fitzpatrick JR, Atluri P, Levit RD, McCormick RC, Marotta NA, Muenzer JR, Kim AY, Woo YJ. Spliced sdf-1 analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner following myocardial infarction. Western Thoracic Surgical Association 36th Annual Meeting. June 23, 2010.
  24. Atluri P, Ullery BW, Howard JL, Hiesinger W, Fitzpatrick JR, Jessup M, Acker MA, Morris RJ, Woo YJ. Rapid onset of fulminant myocarditis portends a favorable prognosis and ability to bridge mechanical support to recovery.  Heart Failure Society of America, 14th Annual Scientific Meeting. September 12, 2010.
  25. Jassar AS, Sims CA, Atluri P, Hari DM, Bavaria JE, Desai ND. Successful outcome after left ventricle laceration, myocardial infarction, and ventricular septal defect caused by penetrating trauma to the heart. Pennsylvania Association for Thoracic Surgery 48th Annual Meeting. October 8, 2010.
  26. Hiesinger W, Perez-Aguilar JM, Atluri P, Marotta N, Frederick JR, Fitzpatrick JR, McCormick RC, Muenzer JR, Levit RD, Yuan LJ, MacArthur JW, Saven JG, Woo YJ. Computational protein design to re-engineer stromal cell-derived factor-1α (SDF) generates a supra-efficient angiogenic polypeptide analog. Nat Medicine. American Heart Association Scientific Sesions 2010. November 14, 2010.
  27. Atluri P,  Ullery BW, MacArthur JW, Kozin ED, Hiesinger W, Donnelly J, Acker MA, Rame JE, Woo YJ. Continuous flow ventricular assist devices improve functional tricuspid regurgitation and right ventricular function. International Society For Heart and Lung Transplantation 31st Annual Meeting and Scientific Sessions. April 14, 2011.
  28. Donnelly JP, Woo YJ, Morris RJ, Goldberg LR, Wald JW, Atluri P, O'Hara ML, Breuer KA, Marble JF, Avrahami NY, Arabia FA, Rogers JG, Acker MA, Rame JE.  Does the “obesity paradox” in chronic heart failure fade after mechanical circulatory support with continuous flow devices: analysis from the Interagency Registry for Mechanically Assisted Circulatory Support. International Society For Heart and Lung Transplantation 31st Annual Meeting and Scientific Sessions. April 14, 2011.
  29. Hiesinger W, Brukman MJ, McCormick RC, Fitzpatrick JR, Frederick JR, Yang EC, Muenzer JR, Marotta NA, Berry MF, Atluri P, Woo YJ. Myocardial tissue elastic properties determined by atomic force microscopy following sdf-1α angiogenic therapy for acute myocardial infarction. Western Thoracic Surgical Association 37th Annual Meeting. June 25, 2011.
  30. Atluri P, Ullery BW, MacArthur JW, Murthy A, Hiesinger W, O’Hara ML, Jessup M, Acker MA,  Rame JE, Woo YJ. Left ventricular assist device implantation is an effective therapy for decreasing pulmonary hypertension and reducing heart transplant allograft right ventricular strain. Heart Failure Society of America, 15th Annual Scientific Meeting. September 18, 2011.
  31. Atluri P,  Goldstone AB, Fairman AS, Ullery BW, MacArthur JW, Shudo Y, Hiesinger W,  O’Hara ML, Fitzpatrick JR, Acker MA, Rame JE, Woo YJ. Quantitative pre-operative risk assessment of right ventricular failure during destination continuous flow left ventricular assist device implantation. International Society For Heart and Lung Transplantation 32nd Annual Meeting and Scientific Sessions. April 19, 2012.
  32. Atluri P, Dymond DJ, Woo YJ. Novel Technique for Implanting a HeartMate II Left ventricular assist device implantation in the presence of a hostile ventricle. International Society For Heart and Lung Transplantation 32nd Annual Meeting and Scientific Sessions. April 20, 2012.
  33. MacArthur JW, Trubelja A, Hiesinger W, Atluri P, Beason DP,  Woo YJ. Mathematically-engineered stromal cell-derived factor 1alpha stem cell cytokine analogue enhances mechanical properties of infarcted myocardium. Western Thoracic Surgical Association 38th Annual Meeting. June 30, 2012.
  34. Goldstone AB, Atluri P, Szeto WY, Trubelja A, Howard J, MacArthur JW,  Gorman RC, Gorman JH, Pochettino AP, Bavaria JE, Acker MA, Hargrove WC, Woo YJ. Minimally Invasive Versus Sternotomy Approaches To Isolated Mitral Valve Repair: A Propensity Matched Comparison.  Western Thoracic Surgical Association 38th Annual Meeting. June 30, 2012.
  35. Fairman AS, Atluri P, MacArthur JW, Yang E, Shudo Y, Hiesinger W,  Acker MA, Woo YJ. Continuous Flow Left Ventricular Assist Device Implant Significantly Improves Pulmonary Hypertension, Right Ventricular Contractility and Tricuspid Valve Competence. American College of Surgeons. October 4, 2012.
  36. Atluri P, Hsiao P, Trubelja A, MacArthur JW, Shudo Y, Yang E, Wang M, Fairman AS, Frederick JR, Woo YJ. Novel Tissue Engineered Angiogenic Construct To Enhance Endothelial Progenitor Cell Mediated Vasculogenic Activity And Normalize Myocardial Biomechanics. American Heart Association Scientific Sesions 2012. November 5, 2012.
  37. Shudo Y, Cohen JE, MacArthur JW, Atluri P, Hsaio P, Yang E, Fairman AS, Trubelja A, Patel J, Miyagawa S, Sawa Y, Woo YJ. Spacially-Oriented, Temporally-Sequential Smc-Epc Bi-Level Cell-Sheet Neovascularizes Ischemic Myocardium. American Heart Association Scientific Sesions 2012. November 5, 2012.
  38. MacArthur JW. Purcell B, Shudo Y, Cohen JE, Fairman AS, Trubelja A, Patel J, Hsaio P, Yang E, Lloyd K, Hiesinger W, Atluri P, Woo YJ. Sustained Release Of Engineered Stromal Cell-Derived Factor 1-Alpha From Injectable Hydrogels Effectively Recruits Endothelial Progenitor Cells And Preserves Ventricular Function Following Myocardial Infarction.American Heart Association Scientific Sesions 2012. November 5, 2012.
  39. Atluri P, Goldstone AB, Fairman AS, MacArthur JW, Shudo Y, Hiesinger W, Howard JL,  Acker MA, Rame JE, Woo YJ. Preoperative Risk Stratification Of Right Ventricular Dysfunction In The Modern, Continuous Flow Left Ventricular Assist Device Era. Southern Thoracic Surgical Association Annual Meeting. November 10, 2012.
  40. Atluri P, Goldstone AB, Kobrin DM, Donnelly JP, Cohen JE, MacArthur JW, Zalewski CM, Howard JL, Shudo Y, Jessup M, Rame JE, Acker MA, Woo YJ. Continuous Flow Left Ventricular Assist Device Implant in the Elderly is Associated with Increased, But Acceptable Risk: Analysis from the INTERMACS Database. The Society of Thoracic Surgeons, 49th Annual Meeting, January 27, 2013.
  41. Atluri P, Woo YJ, Goldstone AB, Fox J, Acker MA, Szeto WY, Hargrove WC. Minimally Invasive Mitral Valve Surgery Can Be Performed With Optimal Outcomes In The Presence Of Left Ventricular Dysfunction. The Society of Thoracic Surgeons, 49th Annual Meeting, January 27, 2013.
  42. Hiroaka A, Atluri P, Kirkpatrick J, MacArthur JW, Cohen JE, Shudo Y, Fairman AS, Woo YJ. Logitundinal Effect of Late Aortic Insufficiency Under Continuous Flow Left Ventricular Assist Device Support.  American College of Cardiology Annual Scientific Sessions, March 10, 2013.
  43. Trubelja A, MacArthur Jr. JW, Sarver JJ, Cohen JE, Shudo Y, Fairman AS, Patel J, Hiesinger W, Atluri P, Woo YJ. Bioengineered SDF-1a Analogue Delivered As An Angiogenic Therapy Significantly Normalizes Elastic And Viscoelastic Material Properties Of Infarcted Cardiac Muscle. Proceedings of ASME 2013 Summer Bioengineering Conference, June 26, 2013.
  44. Atluri P, Opyraso P, MacArthur JW, Cohen JE, Evans SE, Koch CJ, Woo YJ. A Novel, In Vivo Biochemical Assay To Quantify Intracellular Myocardial Oxygen Tension. International Society for Heart Research, Annual International Meeting, July 3, 2013.
  45. Atluri P, Goldstone AB, Fox J, Szeto WY, Hargrove WC. Minimally invasive, port access cardiac surgery can be performed safely with minimal vascular complications utilizing either endoaortic balloon or chitwood clamp. The Society of Thoracic Surgeons 50th Annual Meeting, January 28, 2014.
  46. Atluri P, Gaffey AC , Fairman AS, Goldstone AB, MacArthur JW, Cohen JE, Gutsche JE, Shudo Y, Woo YJ. Combined heart and liver transplantation can be safely performed with excellent short and long-term results. The Society of Thoracic Surgeons 50th Annual Meeting, January 28, 2014.
  47. Jassar AS, Vallabhajosyula P, Desai ND, Atluri P, Gutsche J, Vernick W, McCarthy F, Komlo C, Menon R, Hargrove WC, Bavaria JE, Szeto WY. Direct Innominate Artery Cannulation: A Novel Technique for Antegrade Cerebral Perfusion during Aortic Arch Reconstruction. AATS Aortic Symposium 2014, April 24, 2014.
  48. Atluri P, Miller J, Cohen JE, Fairman AS, Hung G, Gaffey AC, Trubelja A, Patel JB, MacArthur JW, Shudo Y, Chen CS, Woo YJ. Tissue engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function. American Association for Thoracic Surgery 94th Annual Meeting, April 29, 2014.
  49. Gaffey AC, Phillips EC, Howard J, Hung G, Han J, Emery RJ, Goldberg L, Acker MA, Woo YJ, Atluri P. Prior sternotomy and ventricular assist device implant do not adversely impact survival or allograft function following heart transplant. Southern Thoracic Surgical Society Annual Meeting, November 9, 2014.
  50. Gaffey AC, Desai N, Lazar SF, McCarthy FH, Han J, Soopan R, Venkataraman C, McDermott K, Hung G, Wald J, Gutsche J, Acker MA, Atluri P. Extracorporeal membrane oxygenation is an effective bridge strategy to rescue cardiovascular collapse for subsequent transplant, ventricular assist device, or recovery. International Society for Heart & Lung Transplantation 35th Annual Meeting April 8, 2015.
  51. Gaffey AC, Cucchiara AJ, Hung G, Blumberg EA, Acker MA, Atluri P. Transplantation of Center for Disease Control “High Risk” Donor hearts does not adversely impact long term outcomes in adults. International Society for Heart & Lung Transplantation 35th Annual Meeting, April 9, 2015
  52. Sooppan R, Han J, Gaffey AC, Patel P, Hung G, Howard JL, Phillips E, Acker MA, , Eduardo Rame J, Atluri P. Prior Sternotomy does not affect short and long-term ventricular assist device outcomes. International Society for Heart & Lung Transplantation 35th Annual Meeting, April 8, 2015.
  53. Han J, Gaffey AC, Sooppan R, Hung G, Venkaraman CM, Phillips E, Howard JL, Acker MA, Eduardo Rame J, Atluri P. Device geometry does not predict pump thrombosis in heartmate ii patients. International Society for Heart & Lung Transplantation 35th Annual Meeting, April 8, 2015
  54. Zhang DM, Kang J, Restle DJ, Acker MA, Atluri P, Bartoli CR. LVAD-Associated von willebrand factor degradation alters angiogenesis: a mechanistic link between lvad support, gastrointestinal angiodysplasia, and bleeding? International Society for Heart & Lung Transplantation 35th Annual Meeting, April 9, 2015.
  55. Kang J, Zhang DM, Restle DJ, Kallel F, Acker MA, Atluri P, Bartoli CR. Reduced continuous-flow lvad speed does not decrease von willebrand factor degradation. International Society for Heart & Lung Transplantation 35th Annual Meeting, April 8, 2015.
  56. Bartoli CR, Restle DJ, Kang J, Acker MA, Atluri P. Inhibition of ADAMTS-13 by hemoglobin reinstates normal von willebrand factor: a contributor to lvad thrombosis? International Society for Heart & Lung Transplantation 35th Annual Meeting, April 8, 2015.
  57. Birks EJ, Drakos S, Selzman C, Starling R, Cunningham C, Slaughter M, Spevack DM, Salahuddin A, Atluri P, Um J, Lowes B, Patel D, Farrar D, Kallel F, Rame JE. Remission from stage D heart failure (RESTAGE-HF): early results from a prospective multi-center study of myocardial recovery. International Society for Heart & Lung Transplantation 35th Annual Meeting, April 10, 2015.
  58. Gaffey AC, Chen MH, Venkataraman CM, Trubelja A, Rodell CB, Dinh PV, MacArthur JW, Soopan RV, Burdick JA, Atluri P. Injectable shear-thinning hydrogels that deliver endothelial progenitor cells, enhance cell engraftment, increase vasculogenesis, and stabilize regional ischemic myocardium. American Association for Thoracic Surgery 95th Annual Meeting, April 28, 2015.
  59. Atluri P, Gaffey AC, Szeto WY, Hargrove WC. The benefits of port access mitral valve surgery can be safely offered to morbidly obese patients. International Society for Minimally Invasive Cardiothoracic Surgery 2015 Annual Scientific Meeting. May 5, 2015.
  60. Soopan R, Johnson AP, Gaffey AC, Phillips EC, Howard J, Acker MA, Atluri P. Body mass index does not affect survival and is a reliable independent risk predictor of vad thrombosis. 61st Annual American Society for Artificial Internal Organs Meeting, June 26, 2015.
  61. Gaffey AC, Han J, Trubelja A, Chen CW, Phillips EC, McLean RC, Acker MA, Atluri P. INTERMACS 1 patients: can they be rescued with a left ventricular assist device or are they beyond salvage. 61st Annual American Society for Artificial Internal Organs Meeting, June 27, 2015.
  62. Gaffey AC, Hung H, Doll SL, Thomasson AM, Chen CW, Lee J, Goldberg LR, Blumberg EA, Acker MA, Stone F, Atluri P. Infectious Implications of transplanting center for disease control “high risk” donor hearts. Western Thoracic Surgical Association 2015 41st Annual Meeting. June 27, 2015.
  63. Grandin EW, Troutman GS, Zamani P, Mazurek JA, Vaidya A, Atluri P, Forfia P, Tedford RJ, Margulies KB, Rame JE. Indices of pulsatile & resistive afterload and load-dependent vs independent RV dysfunction in HFrEF. Heart Failure Society of America, Annual Meeting 2015, September 26, 2015.
  64. Gaffey AC, Chen CW, Hiesinger W, Chung J, Grandin EW, Porrett PM, Jessup ML, Acker MA, Atluri P. Bridge with a left ventricular assist device to a simultaneous heart and kidney transplant: review of the united network for organ sharing database. American College of Surgeons 2015 Annual Clinical Congress, October 5, 2015.
  65. Chen CW, Gaffey AC, Grandin EW, Acker MA, Atluri P. Short and Long-Term Heart transplant recipient outcomes are adversely affected by donor pH. American College of Surgeons 2015 Annual Clinical Congress, October 5, 2015.
  66. Irons ML, Gaffey AC, Chen CW, Vaidya A, Acker MA, Atluri P. Pre-operative pulmonary hypertension does not impact long-term outcomes following heart transplantation: review of the united network for organ sharing database. International Society for Heart and Lung Transplantation 36th Annual Meeting, April 27, 2016.
  67. Gaffey AC, Chen CW, Chung JJ, Wald J, Acker MA, Atluri P. Prolonged cardiac allograft donor distance does not impact long-term survival. International Society for Heart and Lung Transplantation 36th Annual Meeting, April 28, 2016.
  68. Chen CW, Gaffey AC, Sprys MH, Chung JJ, Margulies KB, Acker MA, Atluri P. Low ejection fraction in young donor hearts is not associated with increased recipient mortality. International Society for Heart and Lung Transplantation 36th Annual Meeting, April 28, 2016.
  69. Renganaden S, Paulsen SJ, Han J, Ta, AH, Dihn P, Gaffey AC, Venkatarman C, Trubelja A, Hung G, Miller JS, Atluri P. In vivo implantation and perfusion of a gel containing 3D printed internal microvascular networks. 10th World Biomaterials Congress, May 20, 2016.
  70. Irons ML, Gaffey AC, Chen CW, Vaidya A, Acker MA, Atluri P. Pre-operative pulmonary hypertension does not impact long-term outcomes following heart transplantation: review of the united network for organ sharing database. 36th Annual International Society for Heart Lung Transplantation Meeting. April 27, 2016.
  71. Grandin EW, Troutman GS, Gulati AA, Zamani P, Mazurek JA, Birati EY, Wald JW, Margulies KB, Atluri P, Rame JE. Clinical outcomes reveal a spectrum of early right heart failure after left ventricular assist device. 36th Annual International Society for Heart Lung Transplantation Meeting.April 28, 2016.
  72. Gaffey AC, Chen CW, Chung JJ, Wald J, Acker MA, Atluri P. Prolonged cardiac allograft donor distance does not impact long-term survival. 36th Annual International Society for Heart Lung Transplantation Meeting.April 28, 2016.
  73. Chen CW, Gaffey AC, Sprys MH, Chung JJ, Margulies KB, Acker MA, Atluri P. Low ejection fraction in young donors is not associated with increased recipient mortality. 36th Annual International Society for Heart Lung Transplantation Meeting.April 28, 2016.
  74. Kang J, Zhang D, Motomura T, Acker M, Atluri P, Bartoli CR. LVAD device design features and operational settings minimize von willebrand factor degredation. 36th Annual International Society for Heart Lung Transplantation Meeting.April 29, 2016.
  75. Grandin EW, Gulati AA, Troutman GS, Zamani P, Mazurek JA, Birati EY, Wald JW, Margulies KB, Atluri P, Rame JE. Mitral regurgitation is associated with right ventricular pulsatile loading and early right heart failure after left ventricular assist device. 36th Annual International Society for Heart Lung Transplantation Meeting.April 30, 2016.
Chapters
  1. Atluri P, Woo YJ. The Cardiovascular System. The Surgical Review, Second Edition. Lippincott, William & Wilkins, Philadelphia, PA, 2005.
  2. Atluri P, Woo YJ. Cardiovascular Disease and Cardiovascular Surgery. The Surgical Review, 3rd Edition. Lippincott, William & Wilkins, Philadelphia, PA, 2009.
  3. Atluri P, Gorman RC, Gorman JH III, Acker MA. Ischemic Mitral Regurgitation. Cardiac Surgery in the Adult, 4th Edition. McGraw Hill 2011.
  4. Shafi B, Atluri P. Cardiac Surgery. The Intensive Care Unit Manual, 2nd Edition. Elsevier 2013.
  5. Atluri P, Acker MA. Ventricular Assist Devices. Current Therapy in Thoracic and Cardiovascular Surgery, 2nd Edition. Elsevier 2013.
  6. Jessup M, Atluri P. Cardiac Transplantation. A Companion to Braunwald’s Heart Disease, 3rd Edition. Elsevier 2013.
  7. Goldstone AB, Atluri P, Hargrove WC. Mitral Valve Replacement via Right Thoractomy. Cardiac Surgical Techniques (how I do the procedure). McGraw Hill, 2014.
  8. Gaffey AC, Atluri P. Cardiovascular Disease and Cardiovascular Surgery. The Surgical Review, 4th Edition, Lippincott Williams & Wilkins, 2015.
Books
  1. Atluri P, Karakousis G, Porrett P, Kaiser L. editors, The Surgical Review, Second Edition. Lippincott Williams & Wilkins. Philadelphia, PA. 2005.
  2. Porrett P, Atluri P, Karakousis, Roses R, Drebin JA. The Surgical Review, Fourth Edition, Lippincott Williams & Wilkins. Philadelphia, PA. 2015.
Invited Commentary
  1. Woo YJ, Atluri P. Reply to the Editor – “Angiogenesis and surgical or endovascular enhancement of non-coronary collateral circulation: a new research field”. J Thor Cardiovasc Surg. 2010; 139:1676-1677
  2. Atluri P. Editorial Commentary – “Myocardial transfection of adeno-hypoxia inducible factor-1a, a novel strategy to potentiate vasculogenesis in ischemic
 
Awards
  American Association for Thoracic Surgery - David C. Sabiston Research Scholarship
 
May 6, 2007 Finalist, C. Walton Lillehei Young Investigators’ Competition
 
  American Association for Thoracic Surgeons - 87th Annual Meeting
 
Nov. 12, 2006 Finalist, Vivien Thomas Young Investigators’ Competition
 
2006 American Heart Association - Scientific Sessions
 
2006 Gordon P. Buzby Surgical Leadership Award
Dept. of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
 
2005 Resident Award for Excellence in Teaching – Top Ten Finalist
American College of Surgeons
 
2005 The William Y. Inouye Award for Excellence in Medical Student Teaching
Dept. of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
 
Oct. 9, 2004 Overall Best Presentation, Best Paper - Resident Award
42nd Annual Meeting of The Pennsylvania Association of Thoracic Surgeons
 
  Alpha Omega Alpha
Albany Medical College, Albany, New York
 
  Dean’s Certificate for Outstanding Research Endeavors
Albany Medical College, Albany, New York
 
  Commendation for Scholastic Excellence
Albany Medical College, Albany, New York
 
  Summa Cum Laude
Union College, Schenectady, New York
 
  Phi Beta Kappa
Union College, Schenectady, New York
 
  Alpha Kappa Delta – National Sociology Honor Society
Union College, Schenectady, New York

Dr. Pavan Atluri
 
footer Terms of Use Legal Disclaimer Site Map Contact Us Financial Assistance About Penn Medicine Privacy Statement
penn medicine